Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granexin gel in diabetic foot ulcers
NCT02667327Phase 3Terminated
- Sponsor
- Xequel Bio
- Start
- Nov 2018
- Primary completion
- May 2020
- Countries
- 5
01
Overview
A Phase 3 trial of zifogaptide in diabetic foot ulcer (DFU), sponsored by Xequel Bio. Started Nov 2018; status: terminated.
02
Drugs
zifogaptide
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02667327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02667327.